These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17689652)
1. Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer. Higgins R; Bussey M; Naumann W; Hall J; Tait D; Haake M Am J Obstet Gynecol; 2007 Aug; 197(2):205.e1-5; discussion 205.e5-7. PubMed ID: 17689652 [TBL] [Abstract][Full Text] [Related]
2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596 [TBL] [Abstract][Full Text] [Related]
3. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV). Wanebo HJ; Chougule P; Ready N; Koness RJ; Akerley W; McRae R; Nigri P; Leone L; Webber B; Safran H Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):77-84. PubMed ID: 10210544 [TBL] [Abstract][Full Text] [Related]
4. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. de Vos FY; Bos AM; Gietema JA; Pras E; Van der Zee AG; de Vries EG; Willemse PH Anticancer Res; 2004; 24(1):345-8. PubMed ID: 15015619 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer. Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087 [TBL] [Abstract][Full Text] [Related]
7. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach. Lupe K; Kwon J; D'Souza D; Gawlik C; Stitt L; Whiston F; Nascu P; Wong E; Carey MS Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):110-6. PubMed ID: 17084542 [TBL] [Abstract][Full Text] [Related]
9. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study. Addeo D; Blank S; Muggia F; Formenti S Anticancer Res; 2008; 28(5B):3143-6. PubMed ID: 19031972 [TBL] [Abstract][Full Text] [Related]
10. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756 [TBL] [Abstract][Full Text] [Related]
11. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022 [TBL] [Abstract][Full Text] [Related]
12. Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients. Schwarz JK; Wahab S; Grigsby PW Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1258-63. PubMed ID: 20932657 [TBL] [Abstract][Full Text] [Related]
13. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011 [TBL] [Abstract][Full Text] [Related]
15. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149 [TBL] [Abstract][Full Text] [Related]
16. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial. Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600 [TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma. Petera J; Odrázka K; Frgala T; Spacek J Gynecol Oncol; 2005 Nov; 99(2):334-8. PubMed ID: 16023181 [TBL] [Abstract][Full Text] [Related]
18. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950 [TBL] [Abstract][Full Text] [Related]
19. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Mundt AJ; Rotmensch J; Waggoner SE; Yamada D; Langhauser C; Fleming GF Gynecol Oncol; 2001 Aug; 82(2):333-7. PubMed ID: 11531289 [TBL] [Abstract][Full Text] [Related]
20. Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811. Kelly WK; Halabi S; Elfiky A; Ou SS; Bogart J; Zelefsky M; Small E; Cancer; 2008 Dec; 113(11):3137-45. PubMed ID: 18989865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]